This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Government said the move would reduce complex bureaucracy and undo the damage caused by 2012 reorganisation, led by then-health secretary Andrew Lansley and which saw the formation of NHS England as an arms-length body in 2013. We have asked the Government for more details on any proposed transition and its impact on pharmacy colleagues.
The History Pharmacy Quality Solutions has hosted performance data on medication-related quality measures in the EQUIPP® platform since 2013. She is a Certified Pharmacy Technician with 12 years of diverse pharmacy experience directed towards patientcare and quality performance success. Sheer et al., References Sheer, R.,
We are going beyond site-level recruitment, focusing our efforts on outreach and engaging with patients to ensure awareness of clinical trials is an option for treatment. Consulting widely with regulators as well as with patients and clinicians is vital to ensure the smooth integration of digital solutions into clinical trials.
In a landmark 2013 decision , a unanimous Supreme Court held that a naturally occurring DNA segment, even when isolated, is a product of nature and therefore does not meet the subject matter eligibility requirement for patentability.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content